EXPERIMENTAL DRUGS / POTENTIAL ANTIBIOTIC THERAPIES AGAINST M. ULCERANS
P218
CLASS
Synthetic organic
TARGET PROTEIN
The enzyme dihydrofolate reductase (DHFR)
MECHANISM OF ACTION
Bactericidal ctivity
DRUG INTERACTION PHASE (APPROVED, INVESTIGATIONAL, EXPERIMENTAL)
Experimental
LINK TO PUBMED
https://pubmed.ncbi.nlm.nih.gov/34046602/
EXTERNAL LINKS
PubChem Compound 66563688 PubChem SID 374883828 GtoPdb Ligand ID 9740
REFERENCE
Riboldi, G. P., Zigweid, R., Myler, P. J., Mayclin, S. J., Cou?ago, R. M., & Staker, B. L. (2020). Identification of P218 as a potent inhibitor of Mycobacterium ulcerans DHFR. RSC Medicinal Chemistry, 12(1), 103?109. https://doi.org/10.1039/D0MD00303D